NO20011211L - Multippel enhet for kontrollert mateffektuavhengig frigivelse av farmasöytiske preparater og fremgangsmåter for fremstilling avsamme - Google Patents
Multippel enhet for kontrollert mateffektuavhengig frigivelse av farmasöytiske preparater og fremgangsmåter for fremstilling avsammeInfo
- Publication number
- NO20011211L NO20011211L NO20011211A NO20011211A NO20011211L NO 20011211 L NO20011211 L NO 20011211L NO 20011211 A NO20011211 A NO 20011211A NO 20011211 A NO20011211 A NO 20011211A NO 20011211 L NO20011211 L NO 20011211L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- pharmaceutical preparations
- multiple unit
- food effect
- dependent release
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 2
- 238000013019 agitation Methods 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- General Preparation And Processing Of Foods (AREA)
- Nonmetallic Welding Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19842753A DE19842753A1 (de) | 1998-09-18 | 1998-09-18 | Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung |
PCT/EP1999/006882 WO2000016748A1 (de) | 1998-09-18 | 1999-09-17 | Agitationsunabhängige pharmazeutische multiple-unit-retardzubereitungen und verfahren zu ihrer herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20011211L true NO20011211L (no) | 2001-03-09 |
NO20011211D0 NO20011211D0 (no) | 2001-03-09 |
Family
ID=7881376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20011211A NO20011211D0 (no) | 1998-09-18 | 2001-03-09 | Multippel enhet for kontrollert mateffektuavhengig frigivelse av farmasøytiske preparater og fremgangsmÕter for fremstilling av samme |
Country Status (29)
Country | Link |
---|---|
US (1) | US6805881B1 (es) |
EP (1) | EP1113787B1 (es) |
JP (1) | JP2002526437A (es) |
KR (1) | KR100660072B1 (es) |
CN (1) | CN1178650C (es) |
AT (1) | ATE260645T1 (es) |
AU (2) | AU5861499A (es) |
BG (1) | BG105325A (es) |
BR (1) | BR9913839A (es) |
CA (1) | CA2344372C (es) |
DE (2) | DE19842753A1 (es) |
DK (1) | DK1113787T3 (es) |
EE (1) | EE04700B1 (es) |
ES (1) | ES2215404T3 (es) |
HK (1) | HK1040932B (es) |
HR (1) | HRP20010198A2 (es) |
HU (1) | HUP0103669A3 (es) |
ID (1) | ID28735A (es) |
IL (2) | IL141532A0 (es) |
NO (1) | NO20011211D0 (es) |
NZ (1) | NZ510563A (es) |
PL (1) | PL195543B1 (es) |
PT (1) | PT1113787E (es) |
RU (1) | RU2235540C2 (es) |
SK (1) | SK285099B6 (es) |
TR (1) | TR200100756T2 (es) |
UA (1) | UA73097C2 (es) |
WO (2) | WO2000016747A1 (es) |
ZA (1) | ZA200101485B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19962924A1 (de) * | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
US20020044962A1 (en) * | 2000-06-06 | 2002-04-18 | Cherukuri S. Rao | Encapsulation products for controlled or extended release |
DE10129725A1 (de) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
AR034813A1 (es) † | 2001-07-20 | 2004-03-17 | Novartis Ag | Composiciones farmaceuticas y uso de las mismas |
DE10300111A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
DE10355461A1 (de) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
US8481565B2 (en) | 2004-12-27 | 2013-07-09 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
US20070129402A1 (en) * | 2004-12-27 | 2007-06-07 | Eisai Research Institute | Sustained release formulations |
EP1685841A1 (en) * | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prevention and treatment of thromboembolic disorders |
DE102005012561B4 (de) | 2005-03-18 | 2008-06-19 | Christian Beer | Verfahren zum Betrieb eines Werkstück-Transfersystems |
DE102005045518A1 (de) * | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung |
DE102005047558A1 (de) * | 2005-10-04 | 2008-02-07 | Bayer Healthcare Ag | Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen |
DE502006009169D1 (en) | 2005-10-04 | 2011-05-05 | Bayer Schering Pharma Ag | NEUE POLYMORPHE FORM VON 5-CHLOR-N-(ä ( 5S )-2-0X0-3-Ä4-( 3-OXO-4-MORPHOLINYL)-PHENYLÜ-1,3-OXAZOLIDIN-5-YLü -METHYL)-2-THIOPHENCARBOXAMID |
DE102005047561A1 (de) * | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
CN100448432C (zh) * | 2006-10-26 | 2009-01-07 | 徐竹青 | 高溶出度尼莫地平分散片的制备方法 |
DE102006051625A1 (de) * | 2006-11-02 | 2008-05-08 | Bayer Materialscience Ag | Kombinationstherapie substituierter Oxazolidinone |
US7952167B2 (en) * | 2007-04-27 | 2011-05-31 | Taiwan Semiconductor Manufacturing Company, Ltd. | Scribe line layout design |
PT2391345E (pt) * | 2009-01-28 | 2014-12-03 | Novartis Ag | Formulações galénicas compreendendo aliscireno |
US20100247646A1 (en) * | 2009-03-26 | 2010-09-30 | Ranbaxy Laboratories Limited | Extended release tablets of nisoldipine |
PT2554168T (pt) | 2010-03-29 | 2018-02-28 | Astellas Pharma Inc | Composição farmacêutica de libertação controlada |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5482525A (en) | 1977-12-13 | 1979-06-30 | Aisan Ind Co Ltd | Exhaust gas recirculation system |
US4226849A (en) * | 1979-06-14 | 1980-10-07 | Forest Laboratories Inc. | Sustained release therapeutic compositions |
US4327725A (en) | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
US4449983A (en) | 1982-03-22 | 1984-05-22 | Alza Corporation | Simultaneous delivery of two drugs from unit delivery device |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
GB8514665D0 (en) * | 1985-06-11 | 1985-07-10 | Eroceltique Sa | Oral pharmaceutical composition |
DE3612212A1 (de) | 1986-04-11 | 1987-10-15 | Basf Ag | Verfahren zur herstellung von festen pharmazeutischen formen |
DE3612211A1 (de) | 1986-04-11 | 1987-10-15 | Basf Ag | Kontinuierliches verfahren zum tablettieren |
DE3720757A1 (de) | 1987-06-24 | 1989-01-05 | Bayer Ag | Dhp-manteltablette |
DE3830353A1 (de) | 1988-09-07 | 1990-03-15 | Basf Ag | Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen |
JPH03145418A (ja) | 1989-10-27 | 1991-06-20 | Sumitomo Pharmaceut Co Ltd | 塩基性薬物塩酸塩の徐放性製剤 |
ES2111065T5 (es) | 1991-04-16 | 2005-06-16 | Nippon Shinyaku Company, Limited | Procedimiento para producir una dispersion solida. |
DE4138513A1 (de) | 1991-11-23 | 1993-05-27 | Basf Ag | Feste pharmazeutische retardform |
DE4413350A1 (de) | 1994-04-18 | 1995-10-19 | Basf Ag | Retard-Matrixpellets und Verfahren zu ihrer Herstellung |
SE9402422D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New beads for controlled release and a pharmaceutical preparation containing the same |
FR2725624B1 (fr) | 1994-10-14 | 1997-01-17 | Jouveinal Inst Rech | Procede de preparation de formes pharmaceutiques a liberation controlee |
DE19504831A1 (de) | 1995-02-14 | 1996-09-05 | Basf Ag | Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose |
-
1998
- 1998-09-18 DE DE19842753A patent/DE19842753A1/de not_active Withdrawn
-
1999
- 1999-09-08 WO PCT/EP1999/006608 patent/WO2000016747A1/de active Application Filing
- 1999-09-08 AU AU58614/99A patent/AU5861499A/en not_active Abandoned
- 1999-09-17 AU AU61918/99A patent/AU750617B2/en not_active Ceased
- 1999-09-17 PT PT99948770T patent/PT1113787E/pt unknown
- 1999-09-17 CN CNB998110299A patent/CN1178650C/zh not_active Expired - Fee Related
- 1999-09-17 HU HU0103669A patent/HUP0103669A3/hu unknown
- 1999-09-17 PL PL99346535A patent/PL195543B1/pl unknown
- 1999-09-17 UA UA2001042576A patent/UA73097C2/uk unknown
- 1999-09-17 IL IL14153299A patent/IL141532A0/xx not_active IP Right Cessation
- 1999-09-17 RU RU2001110355/15A patent/RU2235540C2/ru not_active IP Right Cessation
- 1999-09-17 US US09/787,229 patent/US6805881B1/en not_active Expired - Fee Related
- 1999-09-17 WO PCT/EP1999/006882 patent/WO2000016748A1/de active IP Right Grant
- 1999-09-17 DK DK99948770T patent/DK1113787T3/da active
- 1999-09-17 BR BR9913839-5A patent/BR9913839A/pt not_active Application Discontinuation
- 1999-09-17 DE DE59908764T patent/DE59908764D1/de not_active Expired - Lifetime
- 1999-09-17 JP JP2000573709A patent/JP2002526437A/ja not_active Ceased
- 1999-09-17 NZ NZ510563A patent/NZ510563A/xx unknown
- 1999-09-17 CA CA002344372A patent/CA2344372C/en not_active Expired - Fee Related
- 1999-09-17 KR KR1020017003495A patent/KR100660072B1/ko not_active IP Right Cessation
- 1999-09-17 ID IDW20010651A patent/ID28735A/id unknown
- 1999-09-17 ES ES99948770T patent/ES2215404T3/es not_active Expired - Lifetime
- 1999-09-17 TR TR2001/00756T patent/TR200100756T2/xx unknown
- 1999-09-17 SK SK372-2001A patent/SK285099B6/sk unknown
- 1999-09-17 EP EP99948770A patent/EP1113787B1/de not_active Expired - Lifetime
- 1999-09-17 AT AT99948770T patent/ATE260645T1/de not_active IP Right Cessation
- 1999-09-17 EE EEP200100161A patent/EE04700B1/xx not_active IP Right Cessation
-
2001
- 2001-02-20 IL IL141532A patent/IL141532A/en unknown
- 2001-02-22 ZA ZA200101485A patent/ZA200101485B/en unknown
- 2001-03-09 NO NO20011211A patent/NO20011211D0/no not_active Application Discontinuation
- 2001-03-09 BG BG105325A patent/BG105325A/bg unknown
- 2001-03-16 HR HR20010198A patent/HRP20010198A2/hr not_active Application Discontinuation
-
2002
- 2002-04-11 HK HK02102756.8A patent/HK1040932B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20011211L (no) | Multippel enhet for kontrollert mateffektuavhengig frigivelse av farmasöytiske preparater og fremgangsmåter for fremstilling avsamme | |
HUP0004383A2 (hu) | Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény | |
NO20065638L (no) | Formuleringer med kontrollert frigivelse inneholdende vardenafil | |
DE69520768T2 (de) | Pharmazeutische Zubereitungen, die Fluoxetin enthalten | |
HUP0302131A2 (hu) | Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények | |
NZ262569A (en) | Reducing bone loss by administration of 3,4-diphenylbenzo[b]pyran derivatives | |
DE69620606D1 (de) | Feste oral anzuwendende arzeneiform | |
HUP0104318A2 (hu) | cGMP PDE-5 inhibitort tartalmazó szabályzottan hatóanyagot felszabadító gyógyászati készítmények | |
FR2771291B1 (fr) | Spheroides, procede de preparation et compositions pharmaceutiques | |
MacPhail et al. | Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS | |
CZ2001792A3 (cs) | Farmaceutická kompozice obsahující entakapon a nitakapon a zesíťovaný derivát celulózy | |
NO951498L (no) | Farmasöytisk preparat for behandling av osteoporose | |
AR011919A1 (es) | FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA | |
DK0758889T3 (da) | Faste,farmaceutiske præparater, der indeholder (S)-2-(4-isobutylphenyl)propionsyre som aktiv bestanddel og mikrokrystallins | |
HUP0500842A2 (hu) | Dronedaront tartalmazó gyógyászati készítmény parenterális adagolásra | |
BR9608392A (pt) | Preparação multiparticulada de liberação controlada e forma de dosagem em tablete. | |
WO2005051350A3 (en) | Water dispersible tablet | |
NO20054360L (no) | Nye oxazolderivater, deres fremstilling og anvendelse som farmasotiske preparater | |
NO995685L (no) | Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasoeytiske blandinger | |
MA26788A1 (fr) | COMPOSITIONS PHARMACEUTIQUES DESTINÉES à L'ADMINISTRATION PAR VOIE ORALE DE PHLOROGLUCINOL ET LEUR PRÉPARATION | |
CA2255064A1 (en) | Potassium, sodium and tris oxaprozin salt pharmaceutical formulations | |
NO950950L (no) | Farmasöytisk preparat | |
NO20001846L (no) | Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer | |
AR015724A1 (es) | La utilizacion de un inhibidor del intercambiador entre na+ y h+ para la preparacion de un medicamento destinado al tratamiento o a la profilaxia deenfermedades del sistema nervioso central. | |
AR001687A1 (es) | Producto farmacéutico apropiado para el tratamiento parenteral de daños producidos por enfermedades isquemicas focales permanentes que comprende (s)-adenosil-l-metionina (SAMe) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |